adalimumab

Description:

DDD: 2.9 mg

Clinical Syndromes:

Morphological Classes:

Glomerulonephritis (GN), Epimembranous Glomerulonephritis, Crescentic glomerulonephritis and others, vasculitis, Tubulo-interstitial Damage (TID), Acute interstitial nephritis (AIN) with granulomas ,

References:

NOTE: the following reference list is generated automatically and has not yet been verified.
Automatic PUBMED search: ("adalimumab/adverse effects"[Mesh] OR "adalimumab/toxicity"[Mesh]) AND (nephrotoxicity OR "Kidney Diseases/chemically induced"[Mesh] OR "Kidney Diseases/pathology"[Mesh] OR "Kidney Diseases/physiopathology"[Mesh])

loading references for 'adalimumab' from pubmed ...

Case Reports: